BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, April 20, 2026
Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 1, 2003

View Archived Issues

Artemin potentially useful for neuropathic pain

Read More

Improved penile erection in rats treated with ABT-724

Read More

SB-399885: cognitive effects in rats

Read More

New approach to treatment of postmenopausal women

Read More

R&D highlights from the 3rd Annual Biotech in Europe Investor Forum: ACE BioSciences

Read More

R&D highlights from the 3rd Annual Biotech in Europe Investor Forum: Arpida

Read More

R&D highlights from the 3rd Annual Biotech in Europe Investor Forum: Artesian Therapeutics

Read More

R&D highlights from the 3rd Annual Biotech in Europe Investor Forum: Avontec

Read More

Evidence of beneficial effects for CP-113818 in a preclinical model of AD

Read More

Nemifitide safe and effective in major depressive disorder

Read More

Antiangiogenic and antiproliferative effects described for AP-23573 in tumor cells

Read More

BioInvent and Xoma enter crosslicense agreement

Read More

NIH grant supports Bionomics research on epilepsy

Read More

Enrollment completed in STELLAR 3 pivotal trial of Xyotax

Read More

Progression-free survival prolonged in Avastin study in colorectal cancer

Read More

Expansion of Tranzyme and NeoGenesis collaboration

Read More

Enrollment completed in phase II study of Paxceed

Read More

Positive phase III topline results for Surfaxin in RDS

Read More

Pliva updates pipeline progress

Read More

Meiji Seika describes novel voltage-gated sodium channel blockers

Read More

New tachykinin NK1 antagonists and their use claimed by Kyorin team

Read More

Takeda researchers prepare and test new squalene synthase inhibitors

Read More

Sumitomo patent covers PAR2 inhibitors and their use in inflammatory disorders

Read More

New microbially produced antibiotic identified at Meiji Seika

Read More

Toray scientists present inhibitors of alpha4 integrin-mediated cell adhesion

Read More

Mutual recognition procedure completed for high-dose Symbicort Turbuhaler

Read More

Nebido receives approval in Finland

Read More

Approval to extend phase I trial of I.N.T.

Read More

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for April 17, 2026.
  • Man holding raised arm with illustrated overlay of nerves

    Biohaven reports details on discovery of BHV-2100

    BioWorld Science
    Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
  • New GABA(B) receptor PAMs revealed in Addex Pharma patents

    BioWorld Science
    Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
  • Elderly woman holding illustration of brain with missing puzzle piece

    Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’

    BioWorld
    The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
  • Novel caspase-2 inhibitor shows in vivo neuroprotective effects

    BioWorld Science
    Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing